{"entity":{"id":"nct07527806","kind":"trial","name":"Optimization of Dynamic Neoadjuvant Therapy Strategies for HER2-Positive Breast Cancer Based on HER2-PET/CT Molecular Imaging","aka":[],"tldr":"A phase 2 trial of HER2 PET in Breast cancer, run by Peking University Cancer Hospital & Institute, not yet recruiting.","summary":"Optimization of Dynamic Neoadjuvant Therapy Strategies for HER2-Positive Breast Cancer Based on HER2-PET/CT Molecular Imaging is a phase 2 interventional study registered as NCT07527806 by Peking University Cancer Hospital & Institute, with 156 participants planned, started 2026-05-01 and due to reach its primary completion in 2029-05-01. Interventions recorded: Trastuzumab (Herceptin), Pertuzumab, Combination product: Trastuzumab + Pertuzumab, Docetaxel or Nab-paclitaxel, carboplatin, CDK4/6 inhibitor, Aromatase Inhibitor (AI), ADC. Conditions recorded: Breast Cancer.\n\nLinked to the technology HER2 PET because the registry's title names it (\"her2 pet\") and Breast cancer among its conditions. Registry record only: no result has been read by an editor.","status":"planned","asOf":"2026-09-22","links":[{"label":"ClinicalTrials.gov NCT07527806","url":"https://clinicaltrials.gov/study/NCT07527806"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["breast-cancer"],"sections":[],"technologies":["her2-pet"],"targets":[],"drugs":["trastuzumab","pertuzumab","carboplatin"],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT07527806","phase":"2","setting":"A Prospective, Double-Arm Study on the Optimization of Dynamic Neoadjuvant Therapy Strategies for HER2-Positive Breast Cancer Based on HER2-PET/CT Molecular Imaging","sponsor":"Peking University Cancer Hospital & Institute","enrolled":156,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct07527806/","neighbours":{"cancer":[{"id":"breast-cancer","kind":"cancer","name":"Breast cancer (all types)","route":"/cancers/breast-cancer/"}],"technology":[{"id":"her2-pet","kind":"technology","name":"HER2 PET","route":"/technologies/her2-pet/"}],"drug":[{"id":"carboplatin","kind":"drug","name":"Carboplatin","route":"/drugs/carboplatin/"},{"id":"pertuzumab","kind":"drug","name":"Pertuzumab","route":"/drugs/pertuzumab/"},{"id":"trastuzumab","kind":"drug","name":"Trastuzumab","route":"/drugs/trastuzumab/"}]}}